Australia
# |
Name |
Dividend Per Share |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 2.62
|
June 30, 2024 | USD 169.95 | -0.56% |
|
Australia |
|
2 |
USD 0.07
|
June 30, 2024 | USD 2.33 | 0.08% |
|
Australia |
|
3 |
USD 0.03
|
June 30, 2024 | USD 7.27 | 0.71% |
|
Australia |
|
4 |
USD 0.03
|
June 30, 2024 | USD 0.74 | 0.62% |
|
Australia |
|
5 |
USD -0.00
|
June 30, 2024 | USD 2.46 | 10.79% |
|
Australia |
|
6 |
USD -0.00
|
June 30, 2024 | USD 2.09 | 0.97% |
|
Australia |
|
7 |
USD -0.00
|
June 30, 2024 | USD 2.04 | -5.56% |
|
Australia |
|
8 |
USD -0.00
|
June 30, 2024 | USD 1.67 | 2.45% |
|
Australia |
|
9 |
USD -0.00
|
June 30, 2024 | USD 1.90 | -4.74% |
|
Australia |
|
10 |
USD -0.00
|
June 30, 2024 | USD 1.23 | -0.40% |
|
Australia |
|
11 |
USD -0.00
|
Dec. 31, 2023 | USD 18.33 | -0.84% |
|
Australia |
|
12 |
USD -0.00
|
June 30, 2024 | NA |
|
Australia |
||
13 |
USD -0.00
|
June 30, 2024 | USD 4.80 | 5.03% |
|
Australia |
|
14 |
USD -0.00
|
Dec. 31, 2023 | USD 6.16 | 2.82% |
|
Australia |
|
15 |
USD -0.00
|
June 30, 2024 | USD 0.74 | 1.48% |
|
Australia |
The Clinical Trials company in Australia with the highest Dividend Per Share is CSL Limited (ASX: CSL.AX) at USD 2.62.
The Clinical Trials company in Australia with the lowest Dividend Per Share is Cogstate Limited (ASX: CGS.AX) at USD -0.00.
The top 10 Clinical Trials companies in Australia by Dividend Per Share are CSL Limited, Australian Clinical Labs Limited, Clinuvel Pharmaceuticals Limited, Monash IVF Group Limited, Clarity Pharmaceuticals Ltd, Immutep Limited, Immuron Limited, Incannex Healthcare Limited, Mesoblast Limited and PolyNovo Limited.
The bottom 10 Clinical Trials companies in Australia by Dividend Per Share are Cogstate Limited, Anteris Technologies Ltd, Alterity Therapeutics Limited, Opthea Limited, Telix Pharmaceuticals Limited, PolyNovo Limited, Mesoblast Limited, Incannex Healthcare Limited, Immuron Limited and Immutep Limited.